U.S. market Closed. Opens in 3 hours 40 minutes

AFIB | Acutus Medical, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 0.1420 - 0.1600
52 Week Range 0.0250 - 0.6270
Beta 0.01
Implied Volatility 515.48%
IV Rank 100.00%
Day's Volume 29,195
Average Volume 160,320
Shares Outstanding 29,779,400
Market Cap 4,228,675
Sector Healthcare
Industry Medical - Devices
IPO Date 2020-08-06
Valuation
Profitability
Growth
Health
P/E Ratio -0.71
Forward P/E Ratio N/A
EPS -0.20
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 230
Country USA
Website AFIB
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.
AFIB's peers: WRAP
*Chart delayed
Analyzing fundamentals for AFIB we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very bad and Health is frighteningly weak. For more detailed analysis please see AFIB Fundamentals page.

Watching at AFIB technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on AFIB Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙